Loading chart...



The current price of IQV is 167.77 USD — it has decreased -1.7
IQVIA Holdings Inc. is a global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. Its segments Commercial Solutions and Research & Development Solutions. Commercial Solutions provides information, advanced analytics, technology solutions, health care provider services (including contract sales), and patient engagement services to the Company's life science clients. Its Research & Development Solutions, which primarily serves biopharmaceutical customers, provides outsourced clinical research, clinical trial and real-world research related services. The Technology & Analytics Solutions segment provides mission-critical information, technology solutions and real-world insights and services to the Company's life science clients. The Research & Development Solutions segment primarily serves biopharmaceutical customers and provides outsourced clinical research and clinical trial-related services.
Wall Street analysts forecast IQV stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for IQV is258.31 USD with a low forecast of 215.00 USD and a high forecast of 290.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
IQVIA Holdings Inc revenue for the last quarter amounts to 4.15B USD, increased 8.41
IQVIA Holdings Inc. EPS for the last quarter amounts to 1.61 USD, increased 15.00
IQVIA Holdings Inc (IQV) has 93000 emplpoyees as of June 20 2026.
Today IQV has the market capitalization of 28.00B USD.